BNP Paribas Exane Downgrades Fresenius Medical Care (FMS) to Underperform

July 28, 2026 4:20 AM

BNP Paribas Exane analyst Hugo Solvet downgraded Fresenius Medical Care (NYSE: FMS) from Neutral to Underperform with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found